Morgan Lewis mourns the loss of our former partner and firm Chair, John Shenefield—a man of extraordinary accomplishments who led our firm from 1996-1999 after an illustrious career with the US Department of Justice and who left an indelible mark on our firm, our clients, and the Antitrust bar.
Regular updates on the regulatory, legislative, procedural, and litigation implications of the US Supreme Court’s decision overruling the Chevron doctrine.
We are proud of our reputation in both the legal and the business communities. People know us for our uniquely collaborative work environment, for colleagues who truly care about one another, and for the powerful, innovative solutions we create for our clients.
We believe that Morgan Lewis is an exceptional place to work, and we are looking for exceptional people to join our team.
Companies can expect a climate where critical decisions will be shaped by the new administration’s enforcement priorities and potentially evolving standards, but should also keep in mind the lessons learned from 2024.
Raising the Bar
Raising the Bar
Our FDA lawyers look back at three key themes of FDA activity in drug development in 2024 and provide insight on what 2025 may bring.